Consider Your Liver
Fatty liver disease is extremely common, affecting an estimated 100 million – or 1 out of every 4 – Americans. Although this “silent” disease often has few noticeable symptoms, it can raise your risk of cardiovascular disease, liver failure, and liver cancer. That’s why Capital Digestive Care has invested in expert physicians, leading-edge technology, research, and support for people with nonalcoholic fatty liver disease (NAFLD), now known as metabolic dysfunction-associated steatotic liver disease (MASLD), nonalcoholic steatohepatitis (NASH), now known as metabolic dysfunction-associated steatohepatitis (MASH), and alcoholic fatty liver disease (AFLD).
Capital Digestive Care’s fatty liver disease experts provide a complete continuum of care model with a holistic approach that supports your health through diagnosis, monitoring, and ongoing screening. With our in-house laboratory and integrated clinical research arm, we have everything you need to manage your fatty liver disease in one place.
The American Association for the Study of Liver Diseases adopted new naming conventions for fatty liver disease and its associated conditions. The name changes aim to promote more inclusive and judgment-free care for people with liver disease.
